BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19413733)

  • 1. The value of automated gel column agglutination technology in the identification of true inherited D blood types in massively transfused patients.
    Summers T; Johnson VV; Stephan JP; Johnson GJ; Leonard G
    Transfusion; 2009 Aug; 49(8):1672-7. PubMed ID: 19413733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of weak D with a fully automated solid-phase red cell adherence system.
    Lai M; Mavilia G; d'Onofrio G; Leone G
    Transfusion; 2005 May; 45(5):689-93. PubMed ID: 15847655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate Rh phenotype determination by reticulocyte mRNA typing shortly after multiple transfusions.
    Randen I; Sørensen K; Hauge R; Dahlberg AB; Mirlashari MR; Thompson KM; Kjeldsen-Kragh J
    Haematologica; 2008 Apr; 93(4):627-30. PubMed ID: 18326528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the gel-based DiaMed-ID microtyping system for crossmatching enhances sensitivity.
    Kaur R; Kakkar N; Dhanoa J
    Indian J Pathol Microbiol; 2003 Oct; 46(4):617-20. PubMed ID: 15025357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital.
    Spinella PC; Perkins JG; Grathwohl KW; Repine T; Beekley AC; Sebesta J; Jenkins D; Azarow K; Holcomb JB;
    Crit Care Med; 2007 Nov; 35(11):2576-81. PubMed ID: 17828033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case for stocking O D+ red blood cells in emergency room trauma bays.
    Meyer E; Uhl L
    Transfusion; 2015 Apr; 55(4):791-5. PubMed ID: 25444310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-A antibody transfused with non-group-specific platelets. Serological abnormalities.
    Thomas L; Tuscany FL; Wilner GD
    Arch Pathol Lab Med; 1981 Jan; 105(1):52-3. PubMed ID: 6893913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New techniques for compatibility testing.
    Plapp FV
    Arch Pathol Lab Med; 1989 Mar; 113(3):262-9. PubMed ID: 2493236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte-magnetized technology: an original and innovative method for blood group serology.
    Bouix O; Ferrera V; Delamaire M; Redersdorff JC; Roubinet F
    Transfusion; 2008 Sep; 48(9):1878-85. PubMed ID: 18522706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital.
    Stinger HK; Spinella PC; Perkins JG; Grathwohl KW; Salinas J; Martini WZ; Hess JR; Dubick MA; Simon CD; Beekley AC; Wolf SE; Wade CE; Holcomb JB
    J Trauma; 2008 Feb; 64(2 Suppl):S79-85; discussion S85. PubMed ID: 18376176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of FDA-approved anti-D reagents with partial D red blood cells.
    Judd WJ; Moulds M; Schlanser G
    Immunohematology; 2005; 21(4):146-8. PubMed ID: 16472014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rh blood group system and Rh antibodies].
    Kato T; Ishimaru K; Ikeda H
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():738-42. PubMed ID: 20942177
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological blood transfusion safety and selection of red blood cells issued from hospital blood banks].
    Py JY
    Transfus Clin Biol; 2010 Dec; 17(5-6):334-40. PubMed ID: 21050787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients.
    Gonzalez-Porras JR; Graciani IF; Perez-Simon JA; Martin-Sanchez J; Encinas C; Conde MP; Nieto MJ; Corral M
    Transfusion; 2008 Jul; 48(7):1318-24. PubMed ID: 18422846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pretransfusion bedside agglutination test is not a "Gold Standard"].
    Levy G
    Transfus Clin Biol; 2008 Nov; 15(5):318-21. PubMed ID: 18930684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of recipient Rh phenotype in a chronically transfused child by two-colour immunofluorescence.
    Wagner F
    Transfus Med; 1994 Sep; 4(3):205-8. PubMed ID: 7820227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased immunorejection in unmatched blood transfusions by attachment of methoxypolyethylene glycol on human red blood cells and the effect on D antigen.
    Tan Y; Qiu Y; Xu H; Ji S; Li S; Gong F; Zhang Y
    Transfusion; 2006 Dec; 46(12):2122-7. PubMed ID: 17176324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How I manage donors and patients with a weak D phenotype.
    Flegel WA
    Curr Opin Hematol; 2006 Nov; 13(6):476-83. PubMed ID: 17053462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid Phase Red Cell Adherence Assay: a tubeless method for pretransfusion testing and other applications in transfusion science.
    Ching E
    Transfus Apher Sci; 2012 Jun; 46(3):287-91. PubMed ID: 22475547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of anti-D in D- recipients transfused with D+ red blood cells.
    Yazer MH; Triulzi DJ
    Transfusion; 2007 Dec; 47(12):2197-201. PubMed ID: 17714422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.